Comparison between Sanginita Chemicals Rights Issue 2024 and Solara Active Pharma Sciences Rights Issue 2024.
Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Sanginita Chemicals Rights Issue 2024 and Solara Active Pharma Sciences Rights Issue 2024. Sanginita Chemicals Rights Issue 2024 is listed on NSE while Solara Active Pharma Sciences Rights Issue 2024 is listed on BSE, NSE.
| Sanginita Chemicals Limited | Solara Active Pharma Sciences Ltd | |
|---|---|---|
| Logo |  |  |
| Listing At | NSE | BSE, NSE |
| Terms of Payment | The full amount for Rights Equity Shares of Rs.18 shall be payable by the eligible shareholders at the time of making an application. | Issue Price of Rs.375/- per share is payable as Rs.131.25 per share on Application. The remaining amount will be called within 24 months from the date of allotment in the Issue or within such extended period as may be determined by the Board or Rights Issue Committee of the Company at its sole discretion from time to time. |
| Entitlement | 1 Rights Equity Share(s) for every 2 fully paid-up Equity Shares held on Record Date | 1 Rights Equity Share(s) for every 3 fully paid-up Equity Shares held on Record Date |
| Application Form | Application Form  | Application Form |
| Letter of Offer | Letter of Offer | Letter of Offer |
| Registrar | Purva Sharegistry (India) Pvt.Ltd. | Cameo Corporate Services Ltd. |
| Lead Managers | Fintellectual Corporate Advisors Pvt.Ltd. | Choice Capital Advisors Pvt.Ltd. |
The issue size of Sanginita Chemicals Rights Issue 2024 rights issue is ₹15.54 Crores, whereas Solara Active Pharma Sciences Rights Issue 2024 rights issue size is ₹449.95 Crores.
| Sanginita Chemicals Limited | Solara Active Pharma Sciences Ltd | |
|---|---|---|
| Issue Size | 86,33,850 shares | 1,19,98,755 shares |
| Issue Size (Amount) | ₹15.54 Crores | ₹449.95 Crores |
| Issue Price | ₹18 per share | ₹375 per share |
| Face Value | ₹10 per share | ₹10 per share |
Find all the important dates related to the rights issue. The record date of Sanginita Chemicals Rights Issue 2024 is May 07, 2024 while record date of Solara Active Pharma Sciences Rights Issue 2024 is May 15, 2024.
| Sanginita Chemicals Limited | Solara Active Pharma Sciences Ltd | |
|---|---|---|
| Record Date | May 07, 2024 | May 15, 2024 |
| Credit of Rights Entitlements | May 27, 2024 | |
| Bid/Offer Opens On | May 15, 2024 | May 28, 2024 |
| Renunciation of Rights Entitlements | May 21, 2024 | Jun 05, 2024 |
| Bid/Offer Closes On | May 27, 2024 | Jun 11, 2024 |
| Deemed Date of Allotment | May 30, 2024 | Jun 19, 2024 |
| Credit Date | Jun 05, 2024 | Jun 19, 2024 |
| Listing Date | May 06, 2024 | Jun 20, 2024 |
Comparison of Sanginita Chemicals Rights Issue 2024 and Solara Active Pharma Sciences Rights Issue 2024 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.
| Sanginita Chemicals Limited | Solara Active Pharma Sciences Ltd | |||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial | Sanginita Chemicals Limited Financial Information (Restated Standalone)Sanginita Chemicals Limited's revenue decreased by -24.85% and profit after tax (PAT) rose by 19.57% between the financial year ending with March 31, 2023 and March 31, 2022.
| Solara Active Pharma Sciences Ltd Financial Information (Restated Consolidated)Solara Active Pharma Sciences Ltd's revenue increased by 13.82% and profit after tax (PAT) rose by 61.85% between the financial year ending with March 31, 2023 and March 31, 2022.
| ||||||||||||||||||||||||||||||||||||||||
